Tesamorelin, CJC-1295 no DAC, Ipamorelin Blend

$125.00

Tesamorelin / CJC-1295 (No DAC) / Ipamorelin Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Tesamorelin, CJC-1295 without Drug Affinity Complex (No DAC), and Ipamorelin. Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH), while CJC-1295 (No DAC) is a modified GHRH…

Category: ,

Description

Tesamorelin / CJC-1295 (No DAC) / Ipamorelin Blend is a research peptide formulation combining three well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Tesamorelin, CJC-1295 without Drug Affinity Complex (No DAC), and Ipamorelin. Tesamorelin is a stabilized analog of growth hormone–releasing hormone (GHRH), while CJC-1295 (No DAC) is a modified GHRH analog designed for shorter-duration signaling. Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on growth hormone regulation, pulsatile release dynamics, and coordinated endocrine signaling mechanisms.

Prior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Tesamorelin has been studied for its role in stimulating endogenous growth hormone release and its involvement in metabolic and lipid-related research models. CJC-1295 (No DAC) has been examined for its ability to activate GHRH receptors while maintaining a shorter duration of activity compared to DAC-bound variants. Ipamorelin has been researched for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, metabolic signaling, and endocrine coordination.

Currently, the Tesamorelin / CJC-1295 (No DAC) / Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and integrated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.

The primary concern for peptide researchers today is product purity. NordSci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.

THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.